How This Works Tirzepatide is a novel dual agonist that simultaneously activates GLP1 (glucagonlike peptide1) and GIP (glucosedependent insulinotropic polypeptide) receptors [1] [2]
The tirzepatide glycine complete guide , the tirzepatide glycine B12 compound guide , and the tirzepatide niacinamide complete guide explore these different formulation approaches and what the research says about each
Their Stanford PhD-led Applied Sciences team is also researching broader applications of GLP-1s in extending lifespan
Autophagy 13 , 99113 (2017)
It has been 35 years since GLP-1 was discovered, and it is no longer a new target, but its long-acting effect is far from over
Antimicrobial Peptide Therapy: Offers a promising alternative to antibiotics, capable of treating bacterial infections and multidrug-resistant pathogens by targeting and killing a broad spectrum of microorganisms